Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels

American Journal of Cardiology

Volumn 85, Issue 2, 2000, Pages 140-146

  Zhu, Jianhui ^a   Quyyumi, Arshed A ^b   Norman, James E ^b   Csako, Gyorgy ^c   Waclawiw, Myron A ^b   Shearer, Gene M ^d   Epstein, Stephen E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BACTERIAL INFECTION; BACTERIUM; BLOOD LEVEL; BODY BURDEN; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DISEASE MARKER; FEMALE; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PATHOGENICITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SUPERINFECTION;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033984188     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00653-0     Document Type: Article

References (30)

1. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
2. Toss H., Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibrinogen and c-reactive protein levels in unstable coronary artery disease. Circulation. 96:1997;4204-4210.
3. Berk B.C., Weintraub W.S., Alexander R.W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 65:1990;168-172.
4. de Beer F.C., Hind C.R., Fox K.M., Allan R.M., Maseri A., Pepys M.B. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J. 47:1982;239-243.
5. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
6. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 144:1996;537-547.
7. Zhu J., Quyyumi A.A., Norman J.E., Csako G., Epstein S.E. Cytomegalovirus in the pathogenesis of atherosclerosis the role of inflammation, as reflected by elevated C-reactive protein levels . J Am Coll Cardiol. 34:1999;1738-1743.
8. Melnick J.L., Adam E., Debakey M.E. Cytomegalovirus and atherosclerosis. Eur Heart J. 14:(suppl K):1993;30-38.
9. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., Epstein S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 256:1994;391-394.
10. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., Epstein S.E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 335:1996;624-630.
11. Adam E., Probtsfield J.L., Burek J., McCollum C.H., Melnick J.L., Petrie B.L., Bailey K.R., Debakey M.E. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 2:1987;291-293.
12. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
13. Nieto F.J., Adam E., Sorlie P., Farzadegan H., Melnick J.L., Comstock G.W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 94:1996;922-927.
14. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
15. Thom D.M., Grayston J.T., Siscovitch D.S., Wang S.P., Weiss N.S., Daling J.R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:1992;68-72.
16. Saikku P., Leinonen M., Tenkanen L., Tenkanen L., Linnanmaki E., Ekman M.R., Manninen V., Manttari M., Frick M.H., Huttunen J.K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med. 116:1992;273-278.
17. Kuo C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:1993;841-849.
18. Muhlestein J.B., Hammond E.H., Carlquist J.F., Radicke E., Thomson M.J., Karagounis L.A., Woods M.L., Anderson J.L. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:1996;1555-1561.
19. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D., Camm A.J., Northfield T.C. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 71:1994;437-439.
20. Scragg R.K.R., Fraser A., Metcalf P.A. Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Commun Health. 50:1996;578-579.
21. Pasceri V., Cammarota G., Patti G., Cuoco L., Gasbarrini A., Grillo R.L., Fedeli G., Gasbarrini G., Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Cirulation. 97:1998;1675-1679.
22. Raza-Ahmad A., Klassen G.A., Murphy D.A., Sullivan J.A., Kinley C.E., Landymore R.W., Wood J.R. Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery. Can J Cardiol. 11:1995;1025-1029.
23. Hajjar D.P., Pomerantz K.B., Falcone D.J., Weksler B.B., Grant A.J. Herpes simplex virus infection in human arterial cells implications in arteriosclerosis . J Clin Invest. 80:1987;1317-1321.
24. Jacob H.S., Visser M., Key N.S., Goodman J.L., Moldow C.F., Vercellott G.M. Herpes virus infection of endothelium new insights into atherosclerosis . Trans Am Clin Climatol Assoc. 103:1992;95-104.
25. Sorlie P.D., Adam E., Melnick S.L., Folsom A., Skelton T., Chambless L.E., Barnes R., Melnock J.L. Cytomegalovirus/herpesvirus and carotid atherosclerosis the ARIC study . J Med Virol. 42:1994;33-37.
26. Chiu B., Viira E., Tucker W., Fong I.W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 96:1997;2144-2148.
27. Havlik R.J., Blackwelder W.C., Kaslow R., Castelli W. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. Arteriosclerosis. 9:1989;877-880.
28. Adler S.P., Hur J.K., Wang J.B., Vetrovec G.W. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 177:1998;209-212.
29. Weiss S.W., Roblin P.M., Gaydos C.A., Cummings P., Patton D.L., Schulhoff N., Shani J., Frankel R., Penney K., Quinn T.C., Hammerschlag M.R., Schachter J. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 173:1996;957-963.
30. Fabricant C.G., Fabricant J., Litrenta M.M., Minick C.R. Virus-induced atherosclerosis. J Exp Med. 148:1978;335-340.